158 related articles for article (PubMed ID: 17851708)
1. Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies.
Lehmann HW; Plentz A; von Landenberg P; Küster RM; Modrow S
Clin Rheumatol; 2008 Mar; 27(3):333-8. PubMed ID: 17851708
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
3. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.
Zakrzewska K; Azzi A; De Biasi E; Radossi P; De Santis R; Davoli PG; Tagariello G
J Med Virol; 2001 Oct; 65(2):402-7. PubMed ID: 11536251
[TBL] [Abstract][Full Text] [Related]
4. Human parvovirus B19 infection and antiphospholipid antibodies.
von Landenberg P; Lehmann HW; Modrow S
Autoimmun Rev; 2007 Apr; 6(5):278-85. PubMed ID: 17412298
[TBL] [Abstract][Full Text] [Related]
5. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
6. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis.
Oğuz F; Akdeniz C; Unüvar E; Küçükbasmaci O; Sidal M
J Paediatr Child Health; 2002 Aug; 38(4):358-62. PubMed ID: 12173996
[TBL] [Abstract][Full Text] [Related]
7. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties.
Lunardi C; Tiso M; Borgato L; Nanni L; Millo R; De Sandre G; Severi AB; Puccetti A
Eur J Immunol; 1998 Mar; 28(3):936-48. PubMed ID: 9541589
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
9. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.
Lehmann HW; Kühner L; Beckenlehner K; Müller-Godeffroy E; Heide KG; Küster RM; Modrow S
J Clin Virol; 2002 Aug; 25(2):135-43. PubMed ID: 12367647
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients with arthritis and parvovirus B19 DNA in synovial membranes.
Schmid S; Bossart W; Michel BA; Brühlmann P
Rheumatol Int; 2007 Jun; 27(8):747-51. PubMed ID: 17401566
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
Heinz C; Plentz A; Bauer D; Heiligenhaus A; Modrow S
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):999-1004. PubMed ID: 15906067
[TBL] [Abstract][Full Text] [Related]
13. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy.
Söderlund M; von Essen R; Haapasaari J; Kiistala U; Kiviluoto O; Hedman K
Lancet; 1997 Apr; 349(9058):1063-5. PubMed ID: 9107245
[TBL] [Abstract][Full Text] [Related]
14. IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen.
Venturoli S; Gallinella G; Manaresi E; Gentilomi G; Musiani M; Zerbini M
J Infect Dis; 1998 Dec; 178(6):1826-9. PubMed ID: 9815244
[TBL] [Abstract][Full Text] [Related]
15. Multiple small pulmonary emboli associated with transient antiphospholipid syndrome in human Parvovirus B19 infection.
Asano Y; Sarukawa M; Idezuki T; Harada S; Kaji K; Nakasu I; Igarashi A
Clin Rheumatol; 2006 Jul; 25(4):585-7. PubMed ID: 16421644
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis.
Mimori A; Misaki Y; Hachiya T; Ito K; Kano S
Rheumatol Int; 1994; 14(3):87-90. PubMed ID: 7839075
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
Weissbrich B; Süss-Fröhlich Y; Girschick HJ
Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
[TBL] [Abstract][Full Text] [Related]
18. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus.
Loizou S; Cazabon JK; Walport MJ; Tait D; So AK
Arthritis Rheum; 1997 Jan; 40(1):103-8. PubMed ID: 9008606
[TBL] [Abstract][Full Text] [Related]
19. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses in parvovirus B19 infected patients.
Modrow S; Dorsch S
Pathol Biol (Paris); 2002 Jun; 50(5):326-31. PubMed ID: 12116851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
